You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In an international poll, the discovery of the structure of DNA didn't quite make the top of the list as the biggest medical breakthrough since 1840.
President Bush calls for a law to keep private genetic information.
February's National Geographic gives readers a glimpse into genome research and the life of Francis Collins.
A quick scan of some highlights in today's issue of Nature.
It's nominating season for the Ben Franklin open access award.
Affymax signs a new office lease representing a major expansion for the company.
As seen in a Genome Technology notepad: a humor report from the Plant and Animal Genome meeting.
Proteomics may be complicated, but that didn't stop these scientists from adding quantum physics to the mix.
The Wall Street Journal reports on Pfizer's anticipated new strategy.
Genome Technology hosts its first seminar today. There's still time to submit your career-related questions for the experts.
Mass spec, meet the cosmos.
The science crew at the New York Times launches a blog of their own.
Proving that good buzzwords never die, BioMed Central launches BMC Systems Biology, an open-access journal covering research in this community.
Nobel laureate Paul Nurse writes an opinion piece in the UK's Times to encourage people to let scientists explain a particular kind of stem cell research before banning it.
Berkeley, Calif., becomes the first city to regulate nanotechnology.
Can't get enough: Harvard announces a 50-year expansion plan, including a 500,000-square-foot science complex.
In this column from the RFID Journal, MIT engineer Stephen Miles updates readers on recent progress with the technology.
This week's issue of Science, boiled down for those who only have time to read during their coffee break.
The Omics! Omics! blog weighs in on a grand-scale effort to generate affinity reagents for the human proteome.
A PLoS Biology paper looks at mapping and validating transcriptional regulation in E. coli.
This week in Nature, plenty of good reads.
Check out the early edition of PNAS for reports on Parkinson's biomarkers and DNA folding.
In memoriam: Harvard biochemist Elkan Blout.
Still celebrating RNA: the 50th anniversary of Alexander Rich's double-stranded discovery.
In this PNAS paper, scientists pop on their sunglasses and check out DNA in all its ultraviolet-illuminated glory.
Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.
Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.
The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.
In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.